Statutory Rules 1992 No. 3361
__________________
Health Insurance (1992-1993 Pathology Services Table) Regulations
I, The Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the Health Insurance Act 1973.
Dated 20 October 1992.
BILL HAYDEN
Governor-General
By His Excellency’s Command,
B. HOWE
Minister of State for Health, Housing
and Community Services
____________
Citation
1. These Regulations may be cited as the Health Insurance (1992-1993 Pathology Services Table) Regulations.
Commencement
2. These Regulations commence on 1 November 1992.
Repeal
3. Statutory Rules 1991 No. 442, and 1992 Nos. 23, 46 and 273 are repealed.
Pathology services table
4. The table of pathology services in the Schedule is prescribed for the purposes of subsection 4a (2) of the Health Insurance Act 1973.
SCHEDULE
TABLE OF PATHOLOGY SERVICES
RULES OF INTERPRETATION
1. (1) In this table, unless the contrary intention appears:
“patient episode” means:
(a) a pathology service to which rule 3a refers that is provided in the circumstances described in that rule that relate to the service; and
(b) except in the case of a pathology service to which paragraph (a) refers—a pathology service or pathology services, whether specified in a single item or in more than 1 items, provided for a single patient whose need for the service or services was determined under subsection 16a (1) of the Act on the same day, whether rendered by an approved pathology practitioner or more than 1 approved pathology practitioner on the same day or on different days;
“recognised pathologist” means a medical practitioner recognised as a specialist in pathology under a determination under subsection 61 (3) of the Act;
“the Act” means the Health Insurance Act 1973.
(2) In these Rules, a reference to a request to an approved pathology practitioner includes a reference to a request for a pathologist-determinable service to which subsection 16a (6) of the Act applies.
SCHEDULE—continued
(3) Unless the contrary intention appears, a reference in this table by number to an item that is not included in this table is a reference to the correspondingly numbered item in the general medical services table or the diagnostic imaging services table, as each case requires.
2. (1) If a service is described:
(a) in an item in general terms; and
(b) in another item in specific terms:
only the item that describes the service in specific terms applies to the service.
(2) If:
(a) a service is described in 2 or more items; and
(b) subrule (1) does not apply;
only the item that provides the lower or lowest fee for the service applies to the service.
3. (1) In subrule (2), “service” includes an assay, estimation and test.
(2) Subject to rule 3a, 2 or more pathology services rendered for a patient following 2 or more requests are taken to have been rendered following a single request if:
(a) the services are listed in the same item; and
(b) the patient’s need for the services was determined under subsection 16a (1) of the Act on the same day even if they are rendered by an approved pathology practitioner on more than one day.
3a. (1) Rule 3 does not apply to:
(a) a pathology service specified in item 66201, other than an estimation of cholesterol, fructosamine, lithium or triglycerides; or
(b) the quantitative estimation of 1 or more fractions of neonatal bilirubin specified in item 66273;
if:
SCHEDULE—continued
(c) the service is rendered in relation to a single specimen taken on each of not more than 4 occasions in a period of 24 hours; and
(d) the service is rendered to a patient in a hospital unit where:
(i) the presence of 1 nurse is required for each group of not more than 4 patients; and
(ii) the condition of the patients is continuously observed in relevant respects; and
(e) in order to render the service, an approved pathology practitioner who is a recognised pathologist has to arrange for a member of the laboratory staff of the approved pathology authority concerned to undertake duties in respect of the service that are in addition to the usual duties of the staff member.
(2) Rule 3 does not apply to any of the following pathology services rendered in relation to a single specimen taken on each of not more than 6 occasions in a period of 6 months:
(a) estimation of prothrombin time in respect of a patient undergoing anticoagulant therapy;
(b) quantitative estimation of lithium in respect of a patient undergoing lithium therapy;
(c) a service specified in item 65007 in relation to a patient undergoing chemotherapy for neoplastic disease or immunosuppressant therapy;
(d) a service specified in item 65007 in relation to methotrexate, gold or penicillamine therapy of a patient;
(e) a service specified in item 66201 in relation to methotrexate therapy of a patient;
(f) quantitative estimation of urea, creatinine and electrolytes in relation to:
(i) cis-platinum therapy of a patient; or
(ii) chronic renal failure of a patient being treated in a dialysis program conducted by a recognised hospital.
(3) This rule does not apply in relation to a pathology service unless the account for fees in respect of the service is endorsed with the words “Rule 3 Exemption”.
SCHEDULE—continued
4. If:
(a) a pathology service to which an item of the table applies is rendered for a patient in accordance with a request; and
(b) another pathology service is rendered for the patient in accordance with the request; and
(c) an item of the table:
(i) applies to the other service; and
(ii) is referred to in the item mentioned in paragraph (a);
the other service is treated as if it were part of the service referred to in paragraph (a).
Example:
Dr Proctor requests an extended blood grouping test (covered by item 65019) and the test includes a basic blood grouping test (covered by item 65017). Item 65017 is referred to in item 65019. Benefit is payable under item 65019 for the extended blood grouping test but benefit is not payable separately under item 65017 for the basic blood grouping test.
5. For the purposes of items 65001 to 66200 (inclusive):
(a) if pathology services of a kind referred to in item 65017 or 65019 are rendered for a patient during a period when the patient is in hospital, the item applies only to the first pathology service of that kind rendered for the patient during that period; and
(b) tests (except the tests mentioned in item 65023) carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.
5a. (1) In this rule:
“designated pathology service” means a pathology service specified in item 66241, 66313 or 69241.
SCHEDULE—continued
(2) Subject to subrule (3), if an approved pathology practitioner in an approved pathology authority:
(a) has been requested to render a pathology service that specified 2 or more estimations comprised in a designated pathology service; and
(b) is unable to perform 1 or more, but not all, of the estimations because of the lack of facilities in, or expertise or experience of the staff of, the laboratory of the authority in relation to that estimation or those estimations; and
(c) requests an approved pathology practitioner in another approved pathology authority to render 1 or more, but not all, of the estimations;
the service rendered by the second-mentioned practitioner is taken to be the designated pathology service.
(3) Items 73901 to 73917 (inclusive) do not apply to the second-mentioned approved pathology practitioner in subrule (2).
6. For the purposes of items 66201 to 69200 (inclusive):
(a) if a pathology service involving the measurement of a substance in urine requires a 24 hour urine collection, or calculation of a substance/creatinine ratio, the service is treated as including any estimation of creatinine in other fluids necessary for the calculation; and
(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.
7. For the purposes of items 69201 to 71000 (Inclusive):
(a) “serial examinations or cultures” means examinations or cultures requested on 1 occasion whether or not;
(i) the materials are received on different days by the approved pathology practitioner; or
(ii) the examinations or cultures were requested on 1 or more request forms by the treating practitioner; and
SCHEDULE—continued
(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.
8. For the purposes of items 71001 to 72800 (inclusive):
(a) in items 71025, 71027, 71029 and 71031, the estimation of a single antibody includes qualitative and quantitative assays for that antibody; and
(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.
9. For the purposes of items 72801 to 73040 (inclusive):
(a) “biopsy material” means all tissue received by the approved pathology practitioner from an operation, or a group of operations, performed on a patient at the same time, other than a bone marrow biopsy; and
(b) if:
(i) a pathology service that is the examination of biopsy material is rendered under any of those items; and
(ii) a further pathology service mentioned in any of those items is also rendered using that biopsy material;
those pathology services are treated as 1 pathology service.
10. for the purposes of items 73041 to 73280 (inclusive), “serial examinations” means examinations requested on 1 occasion whether or not:
(a) the materials are received on different days by the approved pathology practitioner; or
(b) the examinations were requested on 1 or more request forms by the treating practitioner.
SCHEDULE—continued
11. (1) For the purposes of this rule and items 73901 to 73921 (inclusive):
“approved pathology authority” has the same meaning as in Division 4a of Part IIa of the Act;
“institution” means a place (other than a hospital, a nursing home or accommodation for aged persons that is attached to a nursing home or situated within a nursing home complex) at which residential accommodation or day care is, or both residential accommodation and day care are, made available to:
(a) disadvantaged children; or
(b) juvenile offenders; or
(c) aged persons; or
(d) chronically ill psychiatric patients; or
(e) homeless persons; or
(f) unemployed persons; or
(g) persons suffering from alcoholism; or
(h) persons addicted to drugs; or
(i) physically or mentally handicapped persons.
“licensed collection centre” has the same meaning as in Part IIa of the Act;
“prescribed laboratory” means a laboratory operated by:
(a) the Commonwealth; or
(b) a State; or
(c) an authority of a State or Territory; or
(d) the Northern Territory; or
(e) the Australian Capital Territory; or
(f) an Australian tertiary education institution.
“specimen collection centre” has the same meaning as in Part IIA of the Act;
“temporary collection centre” has the same meaning as in Part IIA of the Act;
“treating practitioner” has the same meaning as in paragraph 16A (1)(a) of the Act.
SCHEDULE—continued
(2) A service mentioned in items 73901 to 73921 (inclusive) applies to a pathology service when rendered by, or on behalf of, an approved pathology practitioner who is a recognised pathologist unless:
(a) the service is rendered upon a request made in the course of an out-patient service at a recognised hospital; or
(b) the service is rendered upon a request made for a patient who is a private patient in a recognised hospital when the request was made; or
(c) the pathology equipment of a recognised hospital, or prescribed laboratory, is used rendering the service; or
(d) a member of the staff of a recognised hospital, or prescribed laboratory, participates in the service in the course of the member’s employment with the hospital or laboratory.
(3) A service mentioned in items 73901 to 73921 (inclusive) does not apply to a pathology service:
(a) to which subsection 16a (7) of the Act applies; or
(b) unless at least one of items 65001 to 73529 (inclusive) also applies to that service.
(4) If one item of items 73901 to 73917 (inclusive) applies to a patient episode, none of the remainder of those items applies to that patient episode.
(5) Item 73921:
(a) applies only to the approved pathology practitioner or approved pathology authority to whom the specimen mentioned in the item was referred; and
11a. If item 73921 applies to a patient episode, none of items 73901 to 73917 (inclusive) applies to any pathology service rendered by the approved pathology authority or the approved pathology provider in respect of that patient episode.
12. The abbreviations at the end of the table may be used to identify particular pathology services or groups of pathology services.
SCHEDULE—continued
SERVICES AND FEES
GROUP P1—HAEMATOLOGY
| 65001 | Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count—1 or 2 procedures | $5.60 |
| | | |
| 65003 | 3 or more procedures to which item 65001 applies, including any calculation or measurement of erythrocyte or other indices | $7.60 |
| | | |
| 65005 | Examination of blood film, with or without 5 part differential cell count, or 5 part differential cell count with or without examination of blood film, and if performed, any of these additional services—Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitroblue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 65027 | $10.00 |
| | | |
| 65007 | Full blood examination consisting of items 65003 and 65005 | $17.30 |
| | | |
| 65009 | Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by—erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine - 1 or more procedures | $23.00 |
| | | |
| 65011 | Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and 2 of the following—examination for HbH, quantitation of HbA2 or HbF, including any services specified in items 65001, 65003, 65005 and 65007 | $36.00 |
| | | |
SCHEDULE—continued
| 65013 | Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immunochemical techniques, including any services specified in items 65001, 65003, 65005, 65007 and 65015 | $110.00 |
| | | |
| 65015 | Bone marrow examination of aspirated material including any special stains, immunochemical techniques and clot sections where necessary, including any services specified in items 65001, 65003, 65005 and 65007 | $80.00 |
| | | |
| 65017 | Blood grouping, including back-grouping when performed—ABO and Rh (D antigen) | $9.70 |
| | | |
| 65019 | Blood grouping—Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system—1 or more systems, including any services specified in item 65017 | $19.20 |
| | | |
| 65021 | Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 65001, 65003, 65005 and 65007 | $36.00 |
| | | |
| 65023 | Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 65001, 65003, 65005, 65007, 65017 and 65021 including all testing performed on any 1 day | $88.00 |
| | | |
| 65025 | Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected | $15.80 |
| | | |
| 65027 | Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm’s test) including those services specified in items 65005 and 65007 - 1 or more tests | $8.80 |
| | | |
SCHEDULE—continued
| 65029 | Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of—fibrinogen degradation products, fibrin monomer or D-dimer—1 estimation | $12.10 |
| | | |
| 65031 | 2 estimations specified in item 65029 | $16.00 |
| | | |
| 65033 | 3 estimations specified in item 65029 | $19.90 |
| | | |
| 65035 | 4 or more estimations specified in item 65029 | $23.80 |
| | | |
| 65037 | Quantitative assay, by 1 or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin cofactor II, euglobulin clot lysis time and test for lupus anticoagulant—1 estimation | $24.00 |
| | | |
| 65039 | 4 or more estimations specified in item 65037 | $76.00 |
| | | |
| 65041 | Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance—1 or more estimations | $47.50 |
| | | |
| 65043 | Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin —1 or more estimations | $31.50 |
| | | |
| 65045 | Quantitative assay of Von Willebrand’s factor antigen (factor VIII related antigen), Von Willebrand’s factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor —1 estimation | $31.70 |
| | | |
| 65047 | 2 estimations as specified in item 65045 | $45.70 |
| | | |
| 65049 | 3 or more estimations as specified in item 65045 | $59.70 |
| | | |
| | | |
SCHEDULE—continued
| | GROUP P2—CHEMICAL | |
| | | |
| 66201 | Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of—alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea - 1 estimation | $9.80 |
| | | |
| 66203 | 2 estimations specified in item 66201 | $11.85 |
| | | |
| 66205 | 3 estimations specified in item 66201 | $13.90 |
| | | |
| 66207 | 4 estimations specified in item 66201 | $15.95 |
| | | |
| 66209 | 5 estimations specified in item 66201 | $18.00 |
| | | |
| 66211 | 6 or more estimations specified in item 66201 | $20.10 |
| | | |
| 66213 | Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents—bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - 1 or more estimations | $9.50 |
| | | |
| 66215 | Quantitative estimation of cryoglobulins or cryofibrinogen after a positive result for cryoglobulin is obtained in any service specified in item 66213 (including provision of that service)—1 or more estimations | $14.40 |
| | | |
| 66217 | Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents—haemoglobin, porphyrins, reducing substances—each estimation, to a maximum of 3 estimations, taken on separate days | $6.30 |
SCHEDULE—continued
| | | |
| 66219 | Immunological detection of human haemoglobin in faeces, including any additional services specified in item 66217—1 estimation in any 28 day period | $12.00 |
| | | |
| 66223 | Osmolality, estimation by osmometer, in serum or in urine—1 or more estimations | $24.00 |
| | | |
| 66225 | Quantitative estimation of blood gases including tests performed from—pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen—1 or more estimations on 1 specimen | $32.50 |
| | | |
| 66227 | Estimation of blood gases as specified in item 66225 on each specimen in excess of 1 to a maximum of 6 specimens within any 1 day | $8.60 |
| | | |
| 66229 | Calculus, analysis of 1 or more | $29.50 |
| | | |
| 66231 | Drug or chemical assays—including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235, 66237 and 66239, but excluding the surveillance of sports people and athletes for performance improving substances—1 or more assays | $40.00 |
| | | |
| 66233 | Drug assays—including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes—each assay to a maximum of 4 assays within any 28 day period | $20.00 |
| | | |
| 66235 | Drug assay —quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule—1 estimation | $20.00 |
| | | |
SCHEDULE—continued
| 66237 | 2 estimations specified in item 66235 | $28.00 |
| | | |
| 66239 | 3 or more estimations specified in item 66235 | $36.00 |
| | | |
| 66241 | Estimations specified in any of items 66235 to 66239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 3—each estimation to a maximum of 2 estimations | $8.00 |
| | | |
| 66243 | Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid—1 or more examinations or estimations | $31.50 |
| | | |
| 66245 | Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the cholesterol is >6.5mmol/l and triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidaemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity—1 examination to a maximum of 2 examinations in any 12 month period | $29.50 |
| | | |
| 66247 | Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a 28 day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin, or of total relevant enzyme activity—2 or more examinations | $44.00 |
| | | |
| 66255 | Alpha-1-acid glycoprotein, alpha-1-antitrypsin, alpha-2-macroglobulin, quantitative estimation in serum, urine or other body fluid—1 or more estimations | $19.40 |
| | | |
| 66257 | C-1 esterase inhibitor, quantitative estimation | $19.40 |
| | | |
| 66258 | C-1 esterase inhibitor, functional assay | $43.50 |
| | | |
SCHEDULE—continued
| 66259 | Alpha-fetoprotein, beta-2-microglobulin, caeruloplasmin, ferritin (except when part of item 66263), haptoglobulins, microalbumin in proven diabetes mellitus, prealbumin, prostate specific antigen, prostatic acid phosphatase, transferrin (except when part of item 66263) - quantitative estimation in serum, urine or other body fluid—1 estimation | $19.40 |
| | | |
| 66260 | 2 or more estimations as specified in item 66259 | $36.00 |
| | | |
| 66261 | CA-125 antigen, CA-15.3 antigen, CA-19.9 antigen, carcinoembryonic antigen (CEA), mammary serum antigen, mucin-like carcinoma associated antigen (1 or more fractions), neuron-specific enolase, thyroglobulin in serum or other body fluid, in the monitoring or confirmation of malignancy, quantitative estimation—1 estimation | $19.40 |
| | | |
| 66262 | 2 or more estimations specified in item 66261 | $36.00 |
| | | |
| 66263 | Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin | $38.00 |
| | | |
| 66265 | Serum B12, serum folate—1 or more estimations within any 28 day period | $24.00 |
| | | |
| 66267 | Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 estimations in any 12 month period | $43.50 |
| | | |
| 66269 | Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of vitamins A, B1, B2, B3, B6, C, and E —1 or more estimations within any 6 month period | $29.50 |
| | | |
| 66271 | Vitamin D or D fractions - 1 or more estimations | $29.50 |
| | | |
| 66273 | Acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (1 or more fractions), oxalate, pyruvate, serotonin, xylose, zinc—1 quantitative estimation | $24.00 |
| | | |
| 66275 | 2 or more estimations specified in item 66273 | $37.50 |
SCHEDULE—continued
| | | |
| 66277 | Aluminium (except if item 66325 applies), arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium, in blood, urine or other body fluid or tissue—1 or more estimations in any 6 month period | $34.50 |
| | | |
| 66279 | Blood lead estimation, other than for occupational health screening purposes, to a maximum of 3 estimations in any 6 month period—each estimation | $29.50 |
| | | |
| 66281 | Porphyrins (1 or more fractions), catecholamines (1 or more fractions), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), phenylacetic acid (PAA)—quantitative including any qualitative estimations—1 or more estimations | $38.50 |
| | | |
| 66283 | Faecal fat, breath hydrogen measurements in response to loading with disaccharides—1 or more quantitative estimations within any 28 day period | $38.50 |
| | | |
| 66285 | Solid tissue or tissues excluding blood elements—assay of 1 or 2 enzymes | $38.50 |
| | | |
| 66287 | Assay of 3 to 5 enzymes as specified in item 66285 | $72.00 |
| | | |
| 66289 | Assay of 6 or more enzymes as specified in item 66285 | $95.00 |
| | | |
| 66291 | Thyroid function tests, including thyrotrophin (TSH) and at least 1 or more of the following tests—free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin | $40.00 |
| | | |
| 66293 | Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones | $47.50 |
| | | |
| 66295 | Growth hormone suppression by glucose loading, growth hormone stimulation by exercise, dexamethasone suppression test, L-dopa stimulation of growth hormone, where physically performed by a recognised pathologist—1 or more procedures | $11.40 |
| | | |
SCHEDULE—continued
| 66297 | Gonadotrophin releasing hormone stimulation test, synacthen stimulation test, glucagon stimulation test with C-peptide measurement, pentagastrin stimulation of thyrocalcitonin release, secretin stimulation of gastrin release, insulin hypoglycaemia, arginine infusion, where physically performed by a recognised pathologist—1 procedure | $38.00 |
| | | |
| 66299 | 2 or more tests specified in item 66297 | $60.00 |
| | | |
| 66301 | Hormones and hormone binding proteins, quantitative estimation by any method of—ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, human placental lactogen, hydroxyprogesterone, insulin, LH, oestradiol, oestriol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IgF1), free or total testosterone, TSH (where not requested as part of a thyroid function test), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone)—1 estimation | $30.80 |
| | | |
| 66303 | 2 estimations specified in item 66301 | $41.60 |
| | | |
| 66305 | 3 estimations specified in item 66301 | $52.40 |
| | | |
| 66307 | 4 estimations specified in item 66301 | $63.20 |
| | | |
| 66309 | 5 estimations specified in item 66301 | $74.00 |
| | | |
| 66311 | 6 or more estimations specified in item 66301 | $84.80 |
| | | |
| 66313 | Estimations specified in any of items 66301 to 66311 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6—each estimation to a maximum of 5 estimations | $10.80 |
| | | |
| 66315 | Hormone receptor assay on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast—1 or more assays | $77.00 |
| | | |
SCHEDULE—continued
| 66317 | HDL cholesterol, or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugs or with a fasting serum triglyceride level > 2.0 mmol/1—each estimation to a maximum of 4 estimations in any 12 month period | $12.00 |
| | | |
| 66319 | Glycosylated haemoglobin only when performed in the management of established diabetes—each estimation to a maximum of 4 estimations in any 12 month period | $16.20 |
| | | |
| 66321 | Quantitative estimation in the 2nd trimester of pregnancy of alpha-fetoprotein, human chorionic gonadotrophin and oestriol and any other substance to detect foetal abnormality, including any service specified in 1 or more of items 66259, 66301, 73527 or 73529—1 patient episode in that pregnancy | $53.00 |
| | | |
| 66323 | Estimation of tryptic activity in faeces for the investigation of diarrhoea of greater than 4 weeks duration in children less than 6 years of age | $10.80 |
| | | |
| 66325 | Estimation of serum aluminium in a patient in a renal dialysis program—each estimation | $34.50 |
| | | |
| | | |
| | GROUP P3 - MICROBIOLOGY | |
| | | |
| 69201 | Microscopic examination of material other than blood, from 1 or more sites, obtained directly from a patient and excluding material from cultures—wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains—1 or more examinations | $7.20 |
| | | |
| 69203 | Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of 3 estimations taken on separate days including any services specified in item 69201—each estimation | $12.00 |
| | | |
SCHEDULE—continued
| 69205 | The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201—1 or more sites | $18.80 |
| | | |
| 69207 | Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites - skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201 and 69205—1 or more examinations on 1 or more specimens | $27.50 |
| | | |
| 69209 | Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of postoperative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 69207—1 or more sites | $37.50 |
| | | |
| 69211 | Cultural examination (including the detection of clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least 2 selective or enrichment media as well as culture in at least 2 different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201, to a maximum of 3 specimens in any 7 day period—each examination | $45.50 |
| | | |
SCHEDULE—continued
| 69213 | Microscopy with appropriate stains and cultural examinations of 3 specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 69201 | $63.00 |
| | | |
| 69215 | Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing —each set of cultures to a maximum of 3 sets | $16.60 |
| | | |
| 69217 | Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts (simple culture by dip slide is excluded from this item) | $20.10 |
| | | |
| 69219 | Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 69211 has been performed—1 or more estimations | $15.80 |
| | | |
| 69221 | Direct detection of Chlamydia from clinical material, not cultures—1 or more estimations | $9.50 |
| | | |
| 69223 | Direct detection of herpes simplex virus from clinical material, not cultures—1 or more estimations | $9.50 |
| | | |
| 69225 | Investigation for herpes simplex virus (1 or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by 1 or more cultural methods, including any services specified in items 69221 and 69223 | $27.50 |
| | | |
| 69229 | Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule—estimation of 1 antibody | $13.60 |
| | | |
| 69231 | 2 estimations specified in item 69229 | $20.80 |
SCHEDULE—continued
| | | |
| 69233 | 3 estimations specified in item 69229 | $28.00 |
| | | |
| 69235 | 4 estimations specified in item 69229 | $35.20 |
| | | |
| 69237 | 5 estimations specified in item 69229 | $42.40 |
| | | |
| 69239 | 6 or more estimations specified in item 69229 | $49.60 |
| | | |
| 69241 | Estimations specified in any of items 69229 to 69239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6—each estimation to a maximum of 5 estimations | $7.20 |
| | | |
| 69243 | Hepatitis B surface antigen test | $13.40 |
| | | |
| 69245 | Hepatitis B serology to define the immune status of an individual, including at least hepatitis B surface antibody or hepatitis B core antibody tests, including services specified in items 69243, 69247 and 69249 | $18.20 |
| | | |
| 69247 | All serological tests performed for the identification of the agent causing acute hepatitis, which must include hepatitis B surface antigen, hepatitis B core antibody and hepatitis A IgM antibody tests and those services specified in items 69243, 69245 and 69249 | $36.00 |
| | | |
| 69249 | All tests performed in the follow up of a patient with proven hepatitis B, including hepatitis B surface antigen and either hepatitis B antigen or hepatitis B surface antibody tests, including services specified in items 69243 and 69245 | $26.00 |
| | | |
| 69251 | Antibiotics or antimicrobial chemotherapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent—1 or more estimations | $24.00 |
| | | |
| 69253 | All microbiological serology during a pregnancy, which must include the determination of 1 of the following—rubella immune status, specific syphilis serology or hepatitis B surface antigen—including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy | $13.60 |
| | | |
SCHEDULE—continued
| 69255 | All microbiological serology during a pregnancy, which must include the determination of 2 of the following—rubella immune status, specific syphilis serology or hepatitis B surface antigen and including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy | $21.00 |
| | | |
| 69257 | All microbiological serology during a pregnancy, which must include the determination of all 3 of the following - rubella immune status, specific syphilis serology and hepatitis B surface antigen—including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy | $27.50 |
| | | |
| | | |
| | GROUP P4 - IMMUNOLOGY | |
| | | |
| 71061 | Examination for, and characterisation of, a paraprotein or cryoglobulin not previously characterised on serum, urine or other body fluid by immunoelectrophoresis or immunofixation - 1 or more procedures | $28.00 |
| | | |
| 71063 | Examination for, and characterisation of, a paraprotein not previously characterised, by immunoelectrophoresis or immunofixation on serum and urine collected concurrently—2 or more procedures | $42.50 |
| | | |
| 71065 | Examination of CSF and serum concurrently for the presence of oligoclonal proteins—2 or more procedures | $42.50 |
| | | |
| 71067 | Immunoglobulins A, G, M or D, quantitative estimation by any method in serum, urine or other body fluid—1 estimation | $14.50 |
| | | |
| 71069 | 2 estimations as specified in item 71067 | $22.90 |
| | | |
| 71071 | 3 or more estimations as specified in item 71067 | $31.30 |
| | | |
| 71073 | Immunoglobulin G subclasses, quantitative estimation of all 4 subclasses with a maximum of 2 patient episodes in any 12 month period - each patient episode | $102.00 |
| | | |
SCHEDULE—continued
| 71075 | Immunoglobulin E (total), quantitative estimation with a maximum of 2 patient episodes in any 12 month period—each patient episode | $26.00 |
| | | |
| 71077 | Immunoglobulin E (total), quantitative estimation in the follow up of a patient with proven immunoglobulin E secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, with a maximum of 6 patient episodes in any 12 month period—each patient episode | $26.00 |
| | | |
| 71079 | Estimation of specific immunoglobulin G or E antibodies to single or multiple potential allergens, with a maximum of 4 patient episodes in any 12 month period—each patient episode | $23.50 |
| | | |
| 71081 | Total haemolytic complement, quantitative estimation | $19.40 |
| | | |
| 71083 | Complement components C3, C4 or properdin factor B, quantitative estimation —1 estimation | $19.40 |
| | | |
| 71085 | 2 estimations as specified in item 71083 | $27.90 |
| | | |
| 71087 | 3 or more estimations as specified in item 71083 | $36.40 |
| | | |
| 71089 | Complement components or breakdown products of complement proteins not elsewhere specified in an item in this Schedule, quantitative estimation—1 estimation | $28.10 |
| | | |
| 71091 | 2 estimations as specified in item 71089 | $50.90 |
| | | |
| 71093 | 3 or more estimations as specified in item 71089 | $73.70 |
| | | |
| 71097 | Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required | $24.50 |
| | | |
| 71099 | Double-stranded DNA antibodies, quantitative estimation by 1 or more methods other than the Crithidia method | $25.50 |
| | | |
| 71101 | Antibodies to 1 or more extractable nuclear antigens, detection in serum or other body fluids | $16.80 |
| | | |
SCHEDULE—continued
| 71103 | Antibodies to 1 or more extractable nuclear antigens, characterisation after a positive result is obtained by a service specified in item 71101, including that service | $50.00 |
| | | |
| 71105 | Rheumatoid factor, detection by any technique | $8.40 |
| | | |
| 71107 | Quantitation of rheumatoid factor if detected, during a service specified in item 71105, including that service | $19.40 |
| | | |
| 71109 | Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, glomerular basement membrane, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, neutrophil cytoplasm, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome, thyroid stimulating hormone receptor), qualitative or quantitative—estimation of 1 antibody | $33.30 |
| | | |
| 71113 | Estimation of 2 antibodies specified in item 71109 | $50.00 |
| | | |
| 71115 | Estimation of 3 antibodies specified in item 71109 | $62.30 |
| | | |
| 71117 | Estimation of 4 antibodies specified in item 71109 | $70.60 |
| | | |
| 71119 | Antibodies to tissue antigens not elsewhere specified in an item in this Schedule, qualitative or quantitative—estimation of 1 antibody | $16.70 |
| | | |
| 71121 | Estimation of 2 antibodies specified in item 71119 | $20.00 |
| | | |
| 71123 | Estimation of 3 antibodies specified in item 71119 | $23.30 |
| | | |
| 71125 | Estimation of 4 or more antibodies specified in item 71119 | $26.60 |
| | | |
| 71127 | Functional tests for lymphocytes—estimation of proliferation induced by 1 or more mitogens, estimation of proliferation induced by 1 or more antigens or estimation of 1 or more mixed lymphocyte reactions, other than quantitation by microscopy—including a test specified in item 65005, with a maximum of 2 patient episodes in any 12 month period—each patient episode | $170.00 |
| | | |
| 71129 | 2 estimations specified in item 71127 | $210.00 |
SCHEDULE—continued
| | | |
| 71131 | 3 or more estimations specified in item 71127 | $250.00 |
| | | |
| 71135 | Determination of neutrophil function - comprising at least 2 of neutrophil chemotaxis, neutrophil phagocytosis, neutrophil oxidative metabolism, neutrophil bactericidal activity—including any test specified in item 65005 (other than nitroblue tetrazolium reduction slide test), with a maximum of 2 patient episodes in any 12 month period—each patient episode | $200.00 |
| | | |
| 71137 | Determination of cell mediated immunity by multiple antigen delayed type hypersensitivity intradermal skin testing using a minimum of 7 antigens, with a maximum of 2 patient episodes in any 12 month period—each patient episode | $29.00 |
| | | |
| 71139 | Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more specimens of blood, CSF or serous fluid | $100.00 |
| | | |
| 71141 | Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more disaggregated tissue specimens | $220.00 |
| | | |
| 71143 | Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139 or 71141, on a specimen of blood, CSF, serous fluid or disaggregated tissue | $250.00 |
| | | |
| 71145 | Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139, 71141 or 71143, on 2 or more specimens of disaggregated tissues or 1 specimen of disaggregated tissue and 1 or more specimens of blood, CSF or serous fluid | $410.00 |
| | | |
| 71147 | HLA-B27 typing | $33.50 |
| | | |
SCHEDULE—continued
| 71149 | Complete tissue typing for 4 HLA-A and HLA-B Class I antigens (including any separation of leucocytes), including any service specified in item 71147 | $104.00 |
| | | |
| 71151 | Tissue typing for HLA-DR, HLA-DP and HLA-DQ Class II antigens (including any separation of leucocytes)—phenotyping or genotyping of 2 or more antigens | $114.00 |
| | | |
| | | |
| | GROUP P5 - HISTOPATHOLOGY | |
| | | |
| 72801 | Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions | $77.00 |
| | | |
| 72803 | Immediate frozen section diagnosis of biopsy material, including any other histopathology examination | $126.00 |
| | | |
| 72805 | Immunohistochemical investigation of biopsy material by 1 or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination | $95.00 |
| | | |
| 72807 | Electron microscopy of biopsy material including any other histopathology examination | $102.00 |
| | | |
| | | |
| | GROUP P6 - CYTOPATHOLOGY | |
| | | |
| 73043 | Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of precancerous or cancerous changes—1 or more examinations | $14.60 |
| | | |
| 73045 | Cytological examination, other than an examination mentioned in item 73053, for malignancy, including serial examinations and histological services performed on the resulting specimens from washings or brushings from sites not specified in item 73043, or performed on a single specimen of sputum or urine or on 1 or more specimens of other body fluids—1 or more examinations | $28.50 |
| | | |
| 73047 | Cytological examination including examination of a series of 3 sputum or urine specimens for malignant cells | $60.00 |
| | | |
SCHEDULE—continued
| 73049 | Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues | $36.00 |
| | | |
| 73051 | Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance | $67.00 |
| | | |
| 73053 | Routine cytological examination of smears from cervix for detection of precancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia and smears repeated due to an unsatisfactory routine smear—each examination | $12.20 |
| | | |
| 73055 | Cytological examination of smears from cervix in association with the management of previously detected abnormalities including precancerous or cancerous conditions, or the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia, not associated with item 73053—each examination | $12.20 |
| | | |
| 73057 | Cytological examination of smears from vagina, not associated with items 73053 or 73055—each examination | $12.20 |
| | | |
| | GROUP P7 - CYTOGENETICS | |
| | | |
| 73281 | Chromosome studies, including preparation, count and karyotyping of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood—1 or more estimations | $130.00 |
| | | |
| 73283 | Chromosome studies, including preparation, count and karyotyping of blood | $118.00 |
| | | |
| 73285 | Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination—1 or more identifications | $102.00 |
| | | |
SCHEDULE—continued
| | | |
| | GROUP P8 - INFERTILITY AND PREGNANCY TESTS | |
| | | |
| 73521 | Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test) | $6.60 |
| | | |
| 73523 | Semen examination (excluding post vasectomy semen examination), involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and 1 or more chemical tests, with a maximum of 4 examinations in any 12 month period | $27.50 |
| | | |
| 73525 | Sperm antibodies, sperm penetrating ability—1 or more tests | $17.80 |
| | | |
| 73527 | Chorionic gonadotrophin (beta-HCG), qualitative estimation in serum or urine by 1 or more methods, including serial dilution if performed, for diagnosis of pregnancy —1 or more estimations | $9.70 |
| | | |
| 73529 | Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCG—secreting neoplasm, threatened abortion or follow up of abortion | $27.50 |
| | | |
| | | |
| | GROUP P9 - SIMPLE BASIC PATHOLOGY TESTS | |
| | | |
| 73801 | Seminal examination for presence of spermatozoa | $6.30 |
| | | |
| 73802 | Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count—1 procedure | $4.20 |
| | | |
| 73803 | 2 procedures specified in item 73802 | $6.30 |
| | | |
| 73804 | 3 or more procedures specified in item 73802 | $8.40 |
| | | |
| 73805 | Microscopical examination of urine | $4.20 |
| | | |
| 73806 | Pregnancy test by 1 or more immunochemical methods | $10.40 |
| | | |
| 73807 | Microscopical examination of wet film other than urine | $6.30 |
SCHEDULE—continued
| | | |
| 73808 | Microscopical examination of gram stained film | $8.00 |
| | | |
| 73809 | Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method | $2.10 |
| | | |
| 73810 | Microscopical examination screening for fungi in skin, hair or nails —1 or more sites | $6.30 |
| | | |
| 73811 | Mantoux test | $10.40 |
| | | |
| | | |
| | GROUP P10 - PATIENT EPISODE INITIATION | |
| | | |
| 73901 | Initiation of a patient episode which consists only of a service specified in item 73053, 73055 or 73057 from a person who is not in a recognised hospital or a prescribed laboratory | $7.70 |
| | | |
| 73903 | Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is an in-patient of a hospital other than a recognised hospital | $13.80 |
| | | |
| 73905 | Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital | $7.70 |
| | | |
| 73907 | Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a licensed collection centre other than a temporary licensed collection centre | $15.80 |
| | | |
| 73909 | Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital | $15.80 |
| | | |
SCHEDULE—continued
| 73911 | Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority, from a person in the place where the person was residing or in a nursing home or institution | $15.80 |
| | | |
| 73913 | Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905, 73907, 73917 and 73801 to 73811 (inclusive) where the specimen is collected from the person by the person | $9.70 |
| | | |
| 73915 | Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by or on behalf of the treating practitioner | $9.70 |
| | | |
| 73917 | Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a temporary licensed collection centre | $9.70 |
| | | |
| | | |
| | GROUP P11 - SPECIMEN REFERRED | |
| | | |
| 73921 | Referral of specimen by an approved pathology practitioner of an approved pathology authority to another approved pathology practitioner of another approved pathology authority or to another approved pathology authority | $9.70 |
| | | |
| | | |
SCHEDULE—continued
ABBREVIATIONS
A. ABBREVIATIONS FOR GROUPS OF TESTS
Estimations
Group Included in Group Abbreviation Item Numbers
Cardiac Lactate dehydrogenase (LDH) CE 66205
Enzymes aspartate aminotransferase
(AST) and
creatine kinase (CK)
Coagulation Prothrombin time, COAG 65035
Studies activated partial thrombo-
plastin time and two or
more of the following tests-
bleeding time, thrombin
clotting time, fibrinogen
degradation products,
fibrin monomer, D-dimer,
factor XIII screening tests
Electrolytes Sodium (NA) E 66207
potassium (K)
chloride (CL) and
bicarbonate (HCO3)
Lipid Studies Cholesterol (CHOL) and FATS 66203
triglycerides (TRIG)
Liver Function Alkaline phosphatase (ALP), LFT 66211
Tests alanine aminotransferase
(ALT),
aspartate aminotransferase
(AST),
albumin (ALB),
bilirubin (BIL),
gamma glutamyl
transpeptidase (GGT),
lactate dehydrogenase (LDH),
and protein (PROT)
SCHEDULE—continued
Syphilis Rapid plasma reagin test STS 69231
Serology (RPR) or venereal disease
research laboratory
test (VDRL) and
treponema pallidum
haemagglutination test (TPHA)
or fluorescent treponemal
antibody-absorption test
(FTA)
Urea, Urea, U&E 66211
Electrolytes, electrolytes,
Creatine creatinine
B. ABBREVIATIONS FOR INDIVIDUAL TESTS
Abnormal haemoglobins AH 65027
Acetoacetate ACAT 66273
Adrenocorticotrophic hormone (ACTH) ACTH 66301
AFB microscopy & culture of sputum AFB 69213
Alanine aminotransferase ALT 66201
Albumin ALB 66201
Alcohol (ethanol) ETOH 66273
Aldosterone ALDS 66301
Alkaline phosphatase ALP 66201
- isoenzymes ALPI 66245
Alpha fetoprotein AFP 66259
- for Down syndrome testing NTDD 66321
Alpha-1-antitrypsin AAT 66255
Alpha-1-acid glycoprotein AAG 66255
Alpha-2-macroglobulin AMG 66255
Aluminium AL 66277
- renal dialysis ALR 66325
Amino acids AA 66273
Amiodarone AMIO 66235
Amitriptyline AMIT 66235
Ammonia NH3 66273
Amniotic fluid examination AFE 66243
Amylase AMS 66201
Amylobarb AMYL 66235
Androstenedione ANDR 66301
Angiotensin converting enzyme ACE 66273
Antibiotic & antimicrobial chemotherapeutic agents,
quantitative assay QAA 69251
SCHEDULE—continued
Antibodies to
- extractable nuclear antigens
- detection ENA 71101
- characterisation of antibodies if positive ENA ENAP 71103
- nuclear antigens
- detection ANA 71097
- quantitation & measurement of DNA
binding if positive ANA ANAP 71099
- tissue antigens
- acetylcholine receptor ARA 71109
- adrenal cortex ADR 71109
- cardiolipin ACL 71109
- centromere ACA 71119
- gastric parietal cell PCA 71119
- gliadin IgA GLIA 71119
- glomerular basement membrane GBA 71109
- heart AHE 71109
- histone AHI 71109
- insulin AINS 71109
- insulin receptor antibodies INSA 71109
- intercellular cement substance of skin ICCS 71109
- intrinsic factor AIF 71109
- islet cell AIC 71109
- Jo-1 JO1 71119
- keratin KERA 71119
- liver/kidney microsomes LKA 71119
- lymphocyte ALY 71109
- mitochondria MA 71119
- neuron ANE 71109
- neutrophil cytoplasm ANCA 71109
- ovary AOV 71109
- parathyroid PTHA 71109
- platelet APA 71109
- PM-Sc1 PM1 71119
- reticulin RCA 71119
- salivary gland ASG 71109
- Scl-70 SCL 71119
- skeletal muscle SLA 71109
- skin basement membrane SKA 71109
- smooth muscle SMA 71119
- thyroglobulin ATG 71109
- thyroid microsome TMA 71109
- TSH receptor antibody test TSHA 71109
Antibody testing, microbial (see Microbial)
SCHEDULE—continued
Antigen testing, microbial (see Microbial)
Antithrombin III ATH 65037
Apolipoprotein B/A1 ratio APO 66317
Arginine infusion ARIN 66297
Arsenic AS 66277
Aspartate aminotransferase AST 66201
Barbiturate BARB 66235
Beryllium BE 66277
Beta-hydroxybutyrate BHYB 66273
Beta-2-microglobulin BMIC 66259
Bicarbonate HCO3 66201
Bilirubin (all fractions) BILI 66201
- neonatal BILN 66273
Bleeding time BT 65029
Blood
- compatability testing XMAT 65023
- culture BC 69215
- film BF 65005
- full examination FBE 65001
- gases GAS 66225
- group & blood group antibodies BGAB 65021
- group antibodies BGA 65025
- group systems BGS 65019
- grouping-ABO & RH (D antigen) BG 65017
- viscosity VISC 65001
Bone marrow examination
- aspirate BMEA 65015
- trephine BMET 65013
Breath hydrogen test BHT 66283
Bromide BRMD 66235
C-l esterase inhibitor
- quantitative CEIQ 66257
- functional CEIF 66258
C-Peptide CPEP 66301
C-reactive protein CRP 65001
CA-15.3 antigen CA15 66261
CA-l9.9 antigen CA19 66261
CA-125 antigen C125 66261
Cadmium CD 66277
Caeruloplasmin CPLS 66259
Calcitonin CALT 66301
Calcium (total, dialysed or ionized) CA 66201
Calculus analysis CALC 66229
Carbamazepine (Tegretol) CARB 66235
SCHEDULE—continued
Carboxyhaemaglobin COHB 65027
Carcinoembryonic antigen CEA 66261
Catecholamines CAT 66281
Chlamydia
- direct detection from clinical material CHLY 69221
- investigation by cultural methods CHLC 69225
Chloral hydrate CHHY 66235
Chlorazepate CHZP 66235
Chloride CL 66201
Chloroquine CLOQ 66235
Chlorpromazine CHLO 66235
Cholesterol CHOL 66201
- HDL HDLC 66317
Cholinesterase CHSE 66273
Chorionic gonadotrophin
- for pregnancy diagnosis HCG 73527
- for diagnosis of specified conditions HCGD 73529
- for Down syndrome testing NTDD 66321
Chromium CR 66277
Chromosome identification
- by banding technique CSI 73285
- studies CS 73281
- studies of blood CSB 73283
Cimetidine CMTD 66235
Clobazam CLOB 66235
Clomipramine CLOM 66235
Clonazepam (Rivotril) CLON 66235
Clostridium difficile CLDT 69219
Coagulation
- factors (see individual factors)
- time CT 65029
Cold agglutinins CAG 65005, 65027
Compatability testing XMAT 65023
Complement, total haemolytic COM 71081
- components C3 C3 71083
- components C4 C4 71083
- properdin factor B PFB 71083
- other components COMP 71089
Copper CU 66277
Cortisol CORT 66301
Creatine kinase CK 66201
- isoenzymes CKI 66201
- isoenzymes (electrophoresis) CKIE 66245
Creatinine C 66201
SCHEDULE—continued
Cryofibrinogen
- qualitative CFID 66213
- quantitative CFIE 66215
Cryoglobulins
- qualitative CGLD 66213
- quantitative CGLE 66215
- investigation by immunoelectrophoresis
or immunofixation CRYO 71061
Cryptococcal antigen CRYN 69219
CSF antigens
- Haemophilus influenzae HI 69219
- Streptoccus pneumoniae SPN 69219
- Neisseria meningitidis NMG 69219
- group B streptococcus STB 69219
Cultural examination of faeces FCS 69211
Cylic AMP CAMP 66301
Cyclosporin A CLSA 66235
Cystine (cysteine)
- qualitative UCYS 66213
- quantitative CYST 66273
Cytology
- from body fluids, sputum (1 specimen),
urine, washings or brushings BFCY 73045
- from cervix
- routine CCR 73053
- abnormalities CCRA 73055
- from fine needle aspiration of solid tissues FNCY 73049
- aspiration or attendance by a pathologist FNCP 73051
- from skin, nipple discharge, lip, mouth, nose or anus SMCY 73043
- from vagina CVO 73057
- from 3 sputum or urine specimens SPCY 73047
D-dimer test DD 65029
Dehydroepiandrosterone sulphate DHEA 66301
Deoxycortisol DCOR 66301
Desipramine DESI 66235
Dexamethasone DXST 66295
- suppression test DEXA 66301
Diazepam DIAZ 66235
Differential cell count DIFF 65005
Digoxin DIG 66235
Dihydrotesterone DHTS 66301
Diphenylhydantoin (Dilantin) DIL 66235
Direct Coombs test CMBS 65005, 65027
Disopyramide (Rythmodan) DISO 66235
SCHEDULE—continued
DNA, double-stranded antibodies DNAD 71099
Down syndrome/neural tube defects NTDD 66321
Doxepin hydrochloride DOXE 66235
Drugs
- inappropriate dosage - assay DRGO 66231
Electron microscopy of biopsy material EM 72087
Electrophoresis, to demonstrate
- creatine kinase isoenzymes CKIE 66245
- lactate dehydrogenase isoenzymes LDI 66245
- protein classes, or paraprotein EPP1 66245
- protein classes or presence & amount of
paraprotein classes, concurrent collection EPP2 66247
Elements (see individual elements)
Enzyme assays of solid tissue or tissues ENZS 66285
Erythrocyte
- assessment of haemolysis ERYH 65009
- assessment of metabolic enzymes ERYM 65009
- count RCC 65001
- sedimentation rate ESR 65001
Ethosuximide (Zarontin) ETHO 66235
Euglobulin clot lysis time ECLT 65037
Factor
- II FII 65045
- V FV 65045
- VII FVII 65045
- VIII VIII 65045
- IX FIX 65045
- X FX 65045
- XI FXI 65045
- XII FXII 65045
- XIII XIII 65045
- XIII deficiency test F13D 65029
Faecal fat FFAT 66283
- haemoglobin (chemical test) FHC 66217
- haemoglobin (immunological test) FHI 66219
- porphyrins (qualitative test) FPR 66217
- reducing substances FRS 66217
Faeces
- cultural examination FCS 69211
- microscopic examination for parasites OCP 69203
Ferritin (see also Iron studies) FERR 66259
Fibrin monomer FM 65029
Fibrinogen FIB 65029
- degradation products FDP 65029
SCHEDULE—continued
Fitzgerald factor FGF 65045
Flecainide FLEC 66235
Fletcher factor FF 65045
Fluoxetine FLUX 66235
Follicle stimulating hormone FSH 66301
Frozen section diagnosis of biopsy material FS 72803
Fructosamine FRUC 66201
Full blood examination FBE 65007
Gamma glutamyl transpeptidase GGT 66201
Gastrin GAST 66301
Globulin GLOB 66201
Glucagon GLGO 66301
Glucagon stimulation test GSTC 66297
Glucose GLUC 66201
- tolerance test GTT 66201
Glycated haemoglobin (Hb Alc) GHB 66319
Gold AU 66277
Gonadotrophin GRHS 66297
Group B streptococcus antigens STB 69219
Growth hormone GH 66301
- stimulation by exercise or L-dopa GHSE 66295
- suppression by dexamethasone or glucose GHSG 66295
Haematocrit HCT 65001
Haemoglobin estimation HB 65001
Haemoglobinopathy tests HMGP 65011
Haemophilus influenzae antigens HI 69219
Haloperidol HALO 66235
Haptoglobins HGLB 66259
HDL cholesterol HDLC 66317
Heparin
- cofactor II HRNC 65037
- estimation HEPR 65043
Hepatitis serology
- acute hepatitis HEP 69247
- follow-up of proven hepatitis B HEPB 69249
- hepatitis B serology to define immune status HEP1 69245
- hepatitis B surface antigen HBsAg HBSA 69243
- in pregnancy HEPP 69253-57
- hepatitis C HEPC 69229
- hepatitis delta antibody HDA 69229
Herpes simplex virus
- direct detection from clinical material HSV 69223
- investigation by cultural methods HSVC 69225
Heterophile antibodies IM 65005, 65027
SCHEDULE—continued
HIAA (hydroxyindoleacetic acid) HIAA 66273
Histamine HIAM 66273
Histopathology of biopsy material HIST 72801
HLA typing
- HLA-B27 HLAB 71147
- HLA class 1 HLA1 71149
- HLA class 2 HLA2 71151
HMMA (hydroxy-3-methoxymandelic acid HMMA 66281
previously known as VMA)
HMPG (hydroxy methoxy phenylethylene glycol) HMPG 66281
Homovanillic acid HVA 66281
Hormone receptor assay
- breast HRA 66315
- ovary HRO 66315
Hormones:
- adrenocorticotrophic hormone ACTH 66301
- aldosterone ALDS 66301
- androstanedione ANDR 66301
- C-Peptide CPEP 66301
- calcitonin CALT 66301
- cortisol CORT 66301
- cyclic AMP CAMP 66301
- dehydroepiandrosterone sulphate DHEA 66301
- dihydrotestosterone DHTS 66301
- follicle stimulating hormone FSH 66301
- gastrin GAST 66301
- glucagon GLGO 66301
- gonadotrophin GRHS 66297
- growth hormone GH 66301
- stimulation by exercise or L-dopa GHSE 66295
- suppression by dexamethasone or glucose GHSG 66295
- hormone receptor assay
- breast HRA 66315
- ovary HRO 66315
- human placental lactogen HPL 66301
- hydroxyprogesterone OHP 66301
- insulin INS 66301
- insulin, hypoglycaemia test INHY 66297
- luteinizing hormone LH 66301
- oestradiol E2 66301
- oestriol E3 66301
- oestrone E1 66301
- parathyroid hormone PTH 66301
- pentagastrin PSTR 66297
SCHEDULE—continued
- progesterone PROG 66301
- prolactin PROL 66301
- renin REN 66301
- sex hormone binding globulin SHBG 66301
- somatomedin SOMA 66301
- testosterone TES 66301
- thyroid stimulating hormone
(where not requested as part of TFTs) TSH 66301
- urine steroid fraction or fractions USF 66301
- vasoactive intestinal peptide VIP 66301
- vasopressin ADH 66301
- 11 deoxycortisol DCOR 66301
Huhner's test HT 73521
Human placental lactogen HPL 66301
HVA (homovanillic acid) HVA 66281
Hydroxy methoxy phenylethylene glycol HMPG 66281
Hydroxy-3-methoxymandelic acid (previously
known as VMA) HMMA 66281
Hydroxychloroquine HOCQ 66235
Hydroxyindoleacetic acid HIAA 66273
Hydroxyprogesterone OHP 66301
Hydroxyproline HYDP 66273
Imipramine IMIP 66235
- imediate frozen section diagnosis of biopsy material FS 72803
Immunoglobulins
- A IGA 71067
- D IGD 71067
- E (total) IGE 71075-77
- G IGG 71067
- G, 4 subclasses SIGG 71073
- M IGM 71067
Immunohistochemical investigation of biopsy material IHIS 72805
Insulin INS 66301
Insulin, hypoglycaemia test INHY 66297
Intestinal disaccharidases INTD 66285
Iron (see Iron studies)
Iron studies (iron, transferrin & ferritin) IS 66263
L-dopa GHLD 66295
Lactate LACT 66273
- dehydrogenase LDH 66201
- dehydrogenase isoenzymes LDI 66245
Lamellar body phospholipid LBPH 66243
Lead PB 66279
Lecithin/sphingomyelin ratio (amniotic fluid) LS 66243
SCHEDULE—continued
Leucocyte
- count WCC 65001
- 3 surface markers
- blood, CSF, serous fluid LMH3 71139
- tissue LMT3 71141
- 6 surface markers
- blood, CSF, serous fluid or tissue LM6 71143
- blood, CSF, serous fluid & tissue (s) LMHT 71145
Lignocaine LIGN 66235
Lipoprotein electrophoresis LEPG 66245
Lipase LIP 66201
Lithium LI 66201
Lupus anticoagulant LUPA 65037
Luteinizing hormone LH 66301
Lymphocytes
- functional tests
- 1 estimation LF1 71127
- 2 estimations LF2 71129
- 3 estimations LF3 71131
Magnesium MG 66201
Mammary serum antigen MSA 66261
Manganese MN 66277
Mantoux test MANT 73811
Melanogen (see Urine melanin) UML 66213
Mercury HG 66277
Metalbumin detection (Schumm's test) SCHM 65027
Metadrenalines MNEP 66281
Methadone MTDN 66235
Methotrexate MTTA 66235
Methsuximide MSUX 66235
Metronidazole MRDZ 66235
Mexiletine (Mexitil) MEX 66235
Mianserin MIAS 66235
Microalbumin MALB 66259
Microbial antibody testing
- actinomycetes ACT 69229
- adenovirus ADE 69229
- aspergillus ASP 69229
- avian precipitins (bird fancier's disease) APP 69229
- Blastomyces BLM 69229
- Bordetella pertussis BOR 69229
- Borrelia burgdorferi BOB 69229
- Brucella BRU 69229
- Campylobacter jejuni CAM 69229
SCHEDULE—continued
- Candida CAN 69229
- Chlamydia CHL 69229
- Coccidioides CCC 69229
- Coxsackie B1-6 COX 69229
- cryptococus CRY 69229
- cytomegalovirus CMV 69229
- cytomegalovirus serology in pregnancy CMVP 69253-57
- dengue DEN 69229
- diphtheria DIP 69229
- echinococcus ECC 69299
- echo-coxsackie group ECH 69229
- Entamoeba histolytica AMO 69229
- Epstein Barr virus EBV 69229
- fluorescent treponemal antibody
absorption test (FTA-ABS) FTA 69229
- Haemophilus influenzae HUS 69229
- hepatitis delta antibody - anti-delta HDA 69229
- herpes HPA 69229
- Histoplasma HIP 69229
- hydatid HYD 69229
- influenza A FLA 69229
- influenza B FLB 69229
- Legionella pneumophila - serogroup 1 LP1 69229
- Legionella pneumophila - serogroup 2 LP2 69229
- leishmaniasis LEI 69229
- Leptospira LEP 69229
- Listeria LIS 69229
- measles MEA 69229
- Micropolyspora faeni MIC 69229
- mumps MUM 69229
- Murray Valley encephalitis MVE 69229
- Mycoplasma pneumoniae MYC 69229
- Neisseria menigitidis MEN 69229
- Newcastle disease NCD 69229
- parainfluenza 1 PF1 69229
- parainfluenza 2 PF2 69229
- parainfluenza 3 PF3 69229
- paratyphi PTY 69229
- pertussis PER 69229
- poliomyelitis PLO 69229
- Proteus OX 19 POX 69229
- Proteus OXK POK 69229
- Q fever QFF 69229
- rapid plasma reagin test RPR 69229
SCHEDULE—continued
- respiratory syncytial virus RSV 69229
- Ross River virus RRV 69229
- rubella RUB 69229
- Salmonella typhi (H) SAH 69229
- Salmonella typhi (O) SAO 69229
- Schistosoma STO 69229
- streptococcal serology - anti-
DNASE B titre ADNB 69229
- streptococcal serology-anti-streptolysin O titre ASOT 69229
- Streptococcus pneumoniae PCC 69229
- tetanus TET 69229
- Thermoactinomyces vulgaris THE 69229
- thermopolyspora TPS 69229
- Toxocara TOC 69229
- toxoplasma TOX 69229
- TPHA(Treponema pallidum haemagglutin.test) TPHA 69229
- Treponema pallidum haemagglutination test TPHA 69229
- trichinosis TOS 69229
- typhus, Weil-Felix TYP 69229
- Varicella zoster VCZ 69229
- VDRL (Venereal Disease Research Laboratory) VDRL 69229
- Yersinia enterocolitica YER 69229
Microbial antigen testing
- Chlamydia CHLY 69221
- Clostridium difficile CLDT 69219
- cryptococcal antigen CRYN 69219
- group B streptococcus STB 69219
- Haemophilus influenzae HI 69219
- herpes simplex virus HSV 69223
- Neisseria gonorrhoeae GON 69219
- Neisseria meningitidis NMG 69219
- respiratory syncytial virus RSVN 69219
- Streptococcus pneumoniae SPN 66219
- Varicella zoster VCZN 69219
Micropolyspora faeni MIC 69229
Microscopic examination of:
- faeces for parasites OCP 69203
- material other than blood M 69201
Microscopy & culture of:
- material from nose, throat, eye or ear MCS1 69205
- material from skin, superficial sites,
urethra, vagina, cervix or rectum MCS2 69207
- post-op wounds, aspirations of body
cavities, synovial fluid, CSF
SCHEDULE—continued
& op/biopsy specimens MCS3 69209
- specimens of sputum MCS2 69207
- specimens of sputum, urine
or other body fluids for mycobacteria AFB 69213
Mucin-like carcinoma associated antigen MCA 66261
Mycobacteria microscopy & culture of sputum AFB 69213
N-acetyl procainamide NAPC 66235
Neisseria meningitidis antigens NMG 69219
Neural tube defects/Down syndrome NTDD 66321
Neuron-specific enolase NSEN 66261
Neutrophil functions NFT 71135
Nickel NI 66277
Nitrazepam NITR 66235
Nordothiepin NDIP 66235
Norfluoxetine NFLE 66235
Nortriptyline NORT 66235
Oestradiol E2 66301
Oestriol E3 66301
- for Down syndrome testing NTDD 66321
Oestrone E1 66301
Oligoclonal proteins OGP 71065
Osmolality, serum or urine OSML 66223
Oxalate OXAL 66273
Oxazepam OXAZ 66235
PAA (phenyl acetic acid) PAA 66281
Palmitic acid in amniotic fluid PALM 66243
Paracetamol PARA 66235
Paraprotein investigation
- by electrophoresis EPPI 66245
- by immunoelectrophoresis or immunofixation PPRO 71061
- on concurrently collected serum or urine PPSU 71063
Paraquat PARQ 66235
Parathyroid hormone (PTH) PTH 66301
Partial thromboplastin time PTT 65029
Passovy factor PF 65045
Patient episode initiation fees PEI 73901-15
Pentobarbitone PENT 66235
Pentagastrin PSTR 66297
Perhexiline PHEX 66235
pH measurement of body fluids other than urine PH 66213
Phenobarbitone PHBA 66235
Phensuximide PHEN 66235
Phenylacetic acid PAA 66281
Phenytoin PHEY 66235
SCHEDULE—continued
Phosphate PHOS 66201
Phosphatidylglycerol PTGL 66243
Plasminogen PLAS 65037
Platelet
- aggregation PLTG 65041
- count PLTC 65001
Porphyrins (quantitative test, 1 or more
fractions) PR 66281
Potassium K 66201
Prealbumin PALB 66259
Prednisolone PRED 66235
Pregnancy serology
- 1 estimation MSP1 69253
- 2 estimations MSP2 69255
- 3 estimations MSP3 69257
- for Down syndrome testing NTDD 66321
Primidone PRIM 66235
Procainamide PCAM 66235
Progesterone PROG 66301
Prolactin PROL 66301
Prominal PROM 66235
Propranolol PPNO 66235
Prostate specific antigen PSA 66259
Prostatic acid phosphatase ACP 66259
Protein
- C PROC 65037
- S PROS 65037
- quantitative estim. of specific protein
- alpha fetoprotein AFP 66259
- for Down syndrome testing NTDD 66321
- alpha-l-antitrypsin AAT 66255
- alpha-2-macroglobulin AMAC 66255
- beta-2-microglobulin BMIC 66259
- C-l esterase inhibitor CEI 66257
- caeruloplasmin CPLS 66259
- classes by electrophoresis EPPI 66245
- ferritin (see also Iron studies) FERR 66259
- haptoglobins HGLB 66259
- microalbumin MALB 66259
- transferrin (see also Iron studies) TRAN 66259
- total PROT 66201
Prothrombin time PT 65029
Pyruvate PVTE 66273
Quinalbarb QUIB 66235
SCHEDULE—continued
Quinidine QUIN 66235
Quinine QNN 66235
RAST RAST 71079
Red cell folate & serum B12 & serum folate if required RCF 66267
Red cell porphyrins - qualitative test RCP 65027
Renin REN 66301
Respiratory syncytial virus antigens RSVN 69219
Reticulocyte count RETC 65001
Rheumatoid factor RF 71105
- factor quantitation RFQ 71107
RSV- respiratory syncytial virus RSVN 69219
Rubella serology RUB 69229
Salicylate - aspirin SALI 66235
Secretin SSGR 66297
Selenium SE 66277
Semen examination SEE 73523
- for spermatozoa (post vasectomy) SES 73521
Serotonin 5HT 66273
Serology - in pregnancy (see Pregnancy serology)
Serum
- Bl2 B12 66265
- folate (with Bl2) FOL 66265
- folate (with Bl2 red cell folate) RCF 66267
Sex hormone binding globulin SHBG 66301
Snake venom HISS 66231
Sodium NA 66201
Solid tissue or tissues - chemical assays ENZS 66285
Somatomedin SOMA 66301
Sotalol SALL 66235
Specific IgG or IgE antibodies RAST 71079
Sperm antibodies SAB 73525
- penetrating ability SPA 73525
Stelazine STEL 66235
Streptococcus pneumoniae antigens SPN 69219
Strontium SR 66277
Sulthiame (Ospolot) SUL 66235
Synacthen stimulation test SYNS 66297
Syphilis serology STS 69231
Testosterone TES 66301
Thalassaemia studies TS 65011
Theophylline THEO 66235
Thiopentone TOPO 66235
Thioridazine THIO 66235
Thrombin time TT 65029
SCHEDULE—continued
Thyroglobulin TGL 66261
Thyroid
- function tests TFT 66291
- stimulating hormone TSH 66301
Thyrotrophin releasing hormone test TRH 66293
Total free fatty acids TFFA 66273
Transferrin (see also Iron studies) TRAN 66259
Triglycerides TRIG 66201
Trimipramine TRIM 66235
TSH (where not requested as part of a thyroid function test) TSH 66301
Tumour markers
- CA-15.3 antigen CA15 66261
- CA-19.9 antigen CA19 66261
- CA-125 antigen C125 66261
- carcinoembryonic antigen CEA 66261
- mammary serum antigen MSA 66261
- mucin-like carcinoma associated antigen MCA 66261
- neuron specific enolase NSEN 66261
- prostate specific antigen PSA 66259
- prostatic acid phosphatase-1 or more fractions ACP 66259
- thyroglobulin TGL 66261
Tryptic activity in faeces TAF 66323
Urate URAT 66201
Urea U 66201
Urine
- bilirubin UBIL 66213
- cystine (cysteine) UCYS 66213
- haemoglobin UHB 66213
- melanin (melanogen) UML 66213
- microscopy, culture, identification & sensitivity UMCS 69217
- myoglobin UMY 66213
- porphobilinogen UPG 66213
- porphyrins (qualitative test) UPR 66213
- steroid fraction or fractions USF 66301
- urobilinogen UUB 66213
Valproate (Epilim) VALP 66235
Vancomycin VAN 66235
Varicella zoster antigens VCZN 69219
Vasoactive intestinal peptide VIP 66301
Vasopressin ADH 66301
Viscosity of blood or plasma VISC 65001
Vitamins
- B12 RCF 66267
- D VITD 66271
SCHEDULE—continued
- folate RCF 66267
- quantitative estimation of A, B1, B2, B3, B6, C or E VIT 66269
VMA (see HMMA)
Von Willebrands factor VWF 65045
Von Willebrands factor antigen VWA 65045
Warfarin WFR 66235
Xylose XYL 66273
Zinc ZN 66273
____________________________________________________________________
NOTE
1. Notified in the Commonwealth of Australia Gazette on 27 October 1992.